August 13, 2014 / 10:30 PM / 3 years ago

BUZZ-Tekmira Pharmaceuticals Corp: Making more of Ebola drug to take months

1 Min Read

** Drug developer's shares down 10.8 pct at $16.60 in extended trading

** CEO Mark Murray says exploring possibility of making more of its experimental Ebola treatment

** "Making more of the treatment would take months," Murray said on a conference call

** Tekmira shares jumped about 20 pct on Aug. 7 after U.S. FDA modified clinical hold on company's experimental Ebola drug to enable its potential use in humans infected with the virus

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below